Frozen platelets and platelet substitutes in transfusion medicine
1997; Wiley; Volume: 37; Issue: 8 Linguagem: Inglês
10.1046/j.1537-2995.1997.37897424413.x
ISSN1537-2995
AutoresBarbara M. Alving, Thomas Reid, Joseph C. Fratantoni, John S. Finlayson,
Tópico(s)Hematopoietic Stem Cell Transplantation
ResumoTransfusionVolume 37, Issue 8 p. 866-876 Frozen platelets and platelet substitutes in transfusion medicine Barbara M. Alving MD, Barbara M. Alving MD Barbara M. Alving, MD, Professor of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD; current address: Director, Hematology/Medical Oncology Section, Washington Cancer Institute at Washington Hospital Center, 110 Irving Street, N.W., Washington, DC 20010–2975 [Reprint requests]Search for more papers by this authorThomas J. Reid MD, PhD, Thomas J. Reid MD, PhD Thomas J. Reid, MD, PhD, Acting Chief, Hematology and Vascular Biology, Walter Reed Army Institute of Research, Washington, DC.Search for more papers by this authorJoseph C. Fratantoni MD, Joseph C. Fratantoni MD Joseph C. Fratantoni, MD, Director, Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD; current address: Vice President, Biologics C.L. Mcintosh and Associates, Inc., Rockville, MD.Search for more papers by this authorJohn S. Finlayson PhD, John S. Finlayson PhD John S. Finlayson, PhD, Associate Director for Science, Center for Biologies Evaluation and Research, Food and Drug Administration.Search for more papers by this author Barbara M. Alving MD, Barbara M. Alving MD Barbara M. Alving, MD, Professor of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD; current address: Director, Hematology/Medical Oncology Section, Washington Cancer Institute at Washington Hospital Center, 110 Irving Street, N.W., Washington, DC 20010–2975 [Reprint requests]Search for more papers by this authorThomas J. Reid MD, PhD, Thomas J. Reid MD, PhD Thomas J. Reid, MD, PhD, Acting Chief, Hematology and Vascular Biology, Walter Reed Army Institute of Research, Washington, DC.Search for more papers by this authorJoseph C. Fratantoni MD, Joseph C. Fratantoni MD Joseph C. Fratantoni, MD, Director, Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD; current address: Vice President, Biologics C.L. Mcintosh and Associates, Inc., Rockville, MD.Search for more papers by this authorJohn S. Finlayson PhD, John S. Finlayson PhD John S. Finlayson, PhD, Associate Director for Science, Center for Biologies Evaluation and Research, Food and Drug Administration.Search for more papers by this author First published: 27 February 2003 https://doi.org/10.1046/j.1537-2995.1997.37897424413.xCitations: 46 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Lin L., Wiesehahn GP, Morel PA, Corash L.. Use of 8-methoxypsoralen and long-wavelength ultraviolet radiation for decontamination of platelet concentrates. Blood 1989; 74: 517–25. 2 Lin L., Londe H., Janda JM, et al. Photochemical inactivation of pathogenic bacteria in human platelet concentrates. Blood 1994; 83: 2698–706. 3 Margolis-Nunno H., Robinson R., Ben-Hur E., Horowitz B.. Quencher-enhanced specificity of psoralen-photosensitized virus inactivation in platelet concentrates. Transfusion 1994; 34: 802–10. 4 Margolis-Nunno H., Robinson R., Horowitz B., et al. Psoralen-mediated virus photoinactivation in platelet concentrates: enhanced specificity of virus kill in the absence of shorter UVAwavelengths. Photochem Photobiol 1995; 62: 917–22. 5 Margolis-Nunno H., Robinson R., Ben-Hur E., et al. Elimination of potential mutagenicity in platelet concentrates that are virally inactivated with psoralens and ultraviolet A light. Transfusion 1995; 35: 855–62. 6 Murphy S., Rebulla P., Bertolini F., et al. In vitro assessment of the quality of stored platelet concentrates. The BEST (Biomedical Excellence for Safer Transfusion) Task Force of the International Society of Blood Transfusion. Transfus Med Rev 1994; 8: 29–36. 7 EL Snyder, G. Moroff, T. Simon, eds. Symposium on radiolabeling of stored platelet concentrates. Transfusion 1986; 26: 1–42. 8 Snyder EL, Aster RH, Heaton A., et al. Five-day storage of platelets in a non-diethylhexyl phthalate-plasticized container. Transfusion 1992; 32: 736–41. 9 Bertolini F., Murphy S.. A multicenter inspection of the swirling phenomenon in platelet concentrates prepared in routine practice. Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Transfusion 1996; 36: 128–32. 10 Michelson AD. Flow cytometry: a clinical test of platelet function. Blood 1996; 87: 4925–36. 11 Barrett BB, Andersen JW, Anderson KC. Strategies for the avoidance of bacterial contamination of blood components. Transfusion 1993; 33: 228–33. 12 Yomtovian R., Lazarus HM, Goodnough LT, et al. A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets. Transfusion 1993; 33: 902–9. 13 Carr ME Jr, Carr SL, Hantgan RR, Braaten J.. Glycoprotein IIb/IIIa blockade inhibits platelet-mediated force development and reduces gel elastic modulus. Thromb Haemost 1995; 73: 499–505. 14 Reid T., LaRussa V., Esteban G., Hartman K.. Effect of cryoprotectants and freezing on platelet induced clot retraction and platelet activation (abstract). Blood 1995; 86: 860a. 15 Greilich PE, Alving BM, O'Neill KL, et al. A modified thromboelastographic method for monitoring c7E3 Fab in heparinized patients. Anesth Analg 1997; 84: 31–8. 16 Baumgartner HR. The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi. Microvasc Res 1973; 5: 167–79. 17 Heilmann E., Friese P., Anderson S., et al. Biotinylated platelets: a new approach to the measurement of platelet life span. Br J Haematol 1993; 85: 729–35. 18 Dale GL, Wolf RF, Hynes LA, et al. Quantitation of platelet life span in splenectomized dogs. Exp Hematol 1996; 24: 518–23. 19 Peng J., Friese P., Heilmann E., et al. Aged platelets have an impaired response to thrombin as quantitated by P-selectin expression. Blood 1994; 83: 161–6. 20 Wagner SJ, Bardossy L., Moroff G., et al. Assessment of the hemostatic effectiveness of human platelets treated with aminomethyltrimethyl psoralen and UV A light using a rabbit ear bleeding time technique. Blood 1993; 82: 3489–92. 21 Warn-Cramer BJ, Rapaport SI. Evidence suggestive of activation of the intrinsic pathway of blood coagulation after injection of factor Xa/phospholipid into rabbits. Arterioscler Thromb Vasc Biol 1995; 15: 133–9. 22 Giles AR, Mann KG, Nesheim ME. A combination of factor Xa and phosphatidylcholine-phosphatidylserine vesicles bypasses factor VIII in vivo. Br J Haematol 1988; 69: 491–7. 23 Pribluda V., Rotman A.. Dynamics of membrane-cytoskeleton interactions in activated blood platelets. Biochemistry 1982; 21: 2825–32. 24 Hartwig JH. Mechanisms of actin rearrangements mediating platelet activation. J Cell Biol 1992; 118: 1421–42. 25 Winokur R., Hartwig JH. Mechanism of shape change in chilled human platelets. Blood 1995; 85: 1796–804. 26 Read MS, Reddick RL, Bode AP, et al. Preservation of hemostatic and structural properties of rehydrated lyophilized platelets: potential for long-term storage of dried platelets for transfusion. Proc Natl Acad Sci U S A 1995; 92: 397–401. 27 Bode AP. Platelet activation may explain the storage lesion in platelet concentrates. Blood Cells 1990; 16: 109–25; discussion 125–6. 28 Yen RCK, Ho TWC, Blajchman MA. A novel approach to correcting the bleeding associated with thrombocytopenia (abstract). Transfusion 1995; 35 (Suppl): 41S. 29 Cerasoli F. Jr, Wood S., Reichert J., et al. Thromboerythrocytes reduce prolonged ear bleeding time in thrombocytopenic guinea pigs (abstract). Blood 1994; 84: 465a. 30 Coller BS, Springer KT, Beer JH, et al. Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions. J Clin Invest 1992; 89: 546–55. 31 Jackson DP, Sorensen DK, Cronkite EP, et al. Effectiveness of transfusions of fresh and lyophilized platelets in controlling bleeding due to thrombocytopenia. J Clin Invest 1959; 38: 1689–97. 32 Chao FC, Kim BK, Houranieh AM, et al. Infusible platelet membrane microvesicles: a potential transfusion substitute for platelets. Transfusion 1996; 36: 536–42. 33 Fratantoni JC, Poindexter BJ, Bonner RF. Quantitative assessment of platelet morphology by light scattering: a potential method for the evaluation of platelets for transfusion. J Lab Clin Med 1984; 103: 620–31. Citing Literature Volume37, Issue8August 1997Pages 866-876 ReferencesRelatedInformation
Referência(s)